RxDoctor Payments Data

Kevin Jeong, DPM

Podiatrist · Brooklyn, NYNPI 1417362302

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (40.1%), food and beverage and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 26.1% of the total. Reporting peaked in 2021 at $4,146 and has fallen 56.0% since, to $1,824 in 2025. Among podiatrist clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,702in general payments, 2019–2025

Across 78 payments — averaging $124.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$3K
  • Gotham Surgical Solutions & Devices, Inc.$2K
  • Stryker$1K
  • Organogenesis Inc.$1K
  • Osteomed LLC$1K
  • Inari Medical, Inc.$293
  • plus $929 from 11 others

What the payments were for

  • Travel & lodging$3,88940%
  • Food & beverage$3,41435%
  • Education$2,40025%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,702 in reported general payments places this provider in the 95th percentile of 862 podiatrist providers in New York.

See all podiatrist providers in New York

Medicare billing

Part B allowed, 2024
$191,229
Medicare patients
379
Services billed
1,908

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip41$504
Cephalexin15$266
Ciprofloxacin Hcl25$208
Doxycycline Hyclate13$148
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav24$137
Gabapentin15$125
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen24$101
Tramadol Hcl18$95
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim14$67
Oxycodone Hcl11$43

Paid to pharmacies, not to this prescriber.

Other podiatrist in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →